<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Murphy</surname>
    <given-names class="given-names">S. P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Holtz</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lewandowski</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tomasi</surname>
    <given-names class="given-names">T. B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fuji</surname>
    <given-names class="given-names">H.</given-names>
   </name>
  </person-group> (
  <year class="year">2002</year>). 
  <article-title class="article-title">DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells</article-title>. 
  <source class="source">J. Immunol.</source>
  <volume class="volume">169</volume>, 
  <fpage class="fpage">3085</fpage>â€“
  <lpage class="lpage">3093</lpage>
  <pub-id pub-id-type="pmid" class="pub-id">12218125</pub-id>
 </mixed-citation>
</ref>
